{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:18:29Z","timestamp":1771615109352,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cca.2025.120129","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T05:11:18Z","timestamp":1736745078000},"page":"120129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Challenges in the diagnosis and follow-up of Cushing\u2019s syndrome: Evaluating LC-MS\/MS as a confirmation method for urinary free cortisol analyses"],"prefix":"10.1016","volume":"568","author":[{"given":"Ana","family":"Rubio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Tof\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Elorza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"S\u00e1nchez-As\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Barcel\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120129_b0005","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cca.2025.120129_b0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushin\u01f5s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cca.2025.120129_b0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jsbmb.2019.04.004","article-title":"Performance of LC\u2013MS\/MS and immunoassay based 24-h urine free cortisol","volume":"190","author":"O\u03b2wald","year":"2019","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.cca.2025.120129_b0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cca.2015.10.004","article-title":"Salivary cortisol and cortisone by LC-MS\/MS: validation, reference intervals","volume":"451","author":"Antonelli","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120129_b0025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1258\/acb.2007.007119","article-title":"Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays","volume":"45","author":"Wood","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2025.120129_b0030","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563216687335","article-title":"Measuring cortisol in serum, urine and saliva \u2013 are our assays good enough?","volume":"54","author":"El-Farhan","year":"2017","journal-title":"Ann. Clin. Biochem."},{"issue":"9","key":"10.1016\/j.cca.2025.120129_b0035","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/clinchem\/48.9.1511","article-title":"Validation of a high-throughput liquid chromatography\u2013tandem mass spectrometry method for urinary cortisol and cortisone","volume":"48","author":"Taylor","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2025.120129_b0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1258\/0004563053492775","article-title":"Measurement of urinary free cortisol using liquid chromatography-tandem mass spectrometry: comparison with the urine adapted ACS:180 serum cortisol chemiluminescent immunoassay and development of a new reference range","volume":"42","author":"McCann","year":"2005","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2025.120129_b0045","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.clinbiochem.2016.04.009","article-title":"LC-MS\/MS analysis of steroids in the clinical laboratory","volume":"49","author":"Keevil","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2025.120129_b0050","first-page":"123900","article-title":"A dilute and shoot method for urinary free cortisol analysis by LC-MS\/MS","volume":"15","author":"Shen","year":"2024","journal-title":"J. Chromatogr. b. Analyt. Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.cca.2025.120129_b0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jpba.2014.02.003","article-title":"A comprehensive study for the validation of a LC-MS\/MS method for the determination of free and total forms of urinary cortisol and its metabolites","volume":"94","author":"Cuzzola","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2025.120129_b0060","unstructured":"Clinical and Laboratory Standards Institute, 2003. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. Document EP06. Wayne: Clinical and Laboratory Standards Institute. https:\/\/clsi.org\/media\/1437\/ep06a_sample.pdf (accessed 10 November 2024)."},{"key":"10.1016\/j.cca.2025.120129_b0065","unstructured":"Clinical and Laboratory Standards Institute, 2014. Preliminary evaluation of quantitative clinical laboratory methods; approved guideline. 3rd edition. Document EP10-A3. Wayne: Clinical and Laboratory Standards Institute. https:\/\/clsi.org\/media\/3397\/ep10a3amde_sample.pdf (accessed 10 November 2024)."},{"key":"10.1016\/j.cca.2025.120129_b0070","unstructured":"European Medicines Agency. European Medicines Agency, guideline on bioanalytical method validation; European Medicines Agency: Amsterdam, The Netherlands, 2011. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf (accessed 10 November 2024)."},{"issue":"4","key":"10.1016\/j.cca.2025.120129_b0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1575-0922(09)70983-0","article-title":"The medical management of Cushin\u01f5s syndrome","volume":"56","author":"Leal-Cerro","year":"2009","journal-title":"Endocrinol. Nutr."},{"key":"10.1016\/j.cca.2025.120129_b0080","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/biom14050558","article-title":"LC-HRMS and GC-MS profiling of urine free cortisol, cortisone, 6b-, and 18-hydroxycortisol for the evaluation of glucocorticoid and mineralocorticoid disorders","volume":"14","author":"Casals","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.cca.2025.120129_b0085","first-page":"9","article-title":"Big data and reference intervals: rationale, current practices, harmonization and standardization prerequisites and future perspectives of indirect determination of reference intervals using routine data","volume":"2","author":"Mart\u00ednez-S\u00e1nchez","year":"2020","journal-title":"Adv. Lab. Med."},{"issue":"10","key":"10.1016\/j.cca.2025.120129_b0090","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1210\/jc.2015-2507","article-title":"Screening tests for Cushin\u01f5s syndrome: urinary free cortisol role measured by LC-MS\/MS","volume":"100","author":"Ceccato","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2025.120129_b0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3343\/alm.2020.40.4.285","article-title":"Cortisol measurements in Cushin\u01f5s syndrome: immunoassay or mass spectrometry?","volume":"40","author":"Casals","year":"2020","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.cca.2025.120129_b0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3803\/EnM.2022.1549","article-title":"Clinical and technical aspects in free cortisol measurement","volume":"37","author":"Choi","year":"2022","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.cca.2025.120129_b0105","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/clinem\/dgaa105","article-title":"Accuracy of laboratory tests for the diagnosis of Cushing Syndrome","volume":"105","author":"Galm","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2025.120129_b0110","article-title":"Biochemical diagnosis of Cushing\u2019s disease: screening and confirmatory testing","volume":"35","author":"Petersenn","year":"2021","journal-title":"Best Pr. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2025.120129_b0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000446913","article-title":"Investigation for paediatric Cushin\u01f5s syndrome using twenty-four-hour urinary free cortisol determination","volume":"86","author":"Shapiro","year":"2016","journal-title":"Horm. Res. Paediatr."},{"issue":"5","key":"10.1016\/j.cca.2025.120129_b0120","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushin\u01f5s syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.cca.2025.120129_b0125","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/jc.2002-021518","article-title":"Gender-related differences in the presentation and course of Cushin\u01f5s disease","volume":"88","author":"Giraldi","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:35:49Z","timestamp":1740382549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":25,"alternative-id":["S0009898125000087"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120129","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the diagnosis and follow-up of Cushing\u2019s syndrome: Evaluating LC-MS\/MS as a confirmation method for urinary free cortisol analyses","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120129"}}